Posts - CLL Support | HealthUnlocked
All posts for December 2012
HAPPY NEW YEAR WISHES for 2013
Happy New Year wishes - Thank you for coming together and making this forum...
TAP and the Strategy for UK Life Sciences: One Year On
Leukaemia and Lymphoma Research have written an article about the recognition o...
New prognostic markers and better understanding of risk groups?
A recent study has brought together prognostic data to include the recently disc...
Want to take advantage of all our features? Just log in!
or
New Horizon in Oral Medication for Blood Cancer Treatment
Andrew Schorr recorded this interview with the president of The American Society...
What does it mean when platelets continue to decline while on FCR?
Have had two rounds of FCR so far.
Advantages of having CLL?
There must be silver linings to the clouds of CLL. What positives have come out...
Medical breakthrough to save millions of lives
Perhaps you thought this blog was news of some new anti-cancer drug, but it's th...
People experiences.
Sharing your stories does help others, the heterogeneous nature of CLL means we ...
CLL patient advocate and journalist, Andrew Schorr shares his story with CLL patient Dr Brian Koffman from the other side of the lens.
A Personal Perspective on CLL and Myelofibrosis Progress...
Risk categories and refractory CLL in the era of chemoimmunotherapy
This full paper has just become available and it is an important topic, unfortun...
An interesting development in CAR t-cell research
New research from Sloan-Kettering Cancer Center investigates an alternative me...
The Age Old Excuse Campaign
MACMILLAN'S AGE OLD EXCUSE CAMPAIGN
We all have different needs a...
Implications of new prognostic markers in chronic lymphocytic leukaemia. Advanced topic
Implications of new prognostic markers in chronic lymphocytic leukemia
by Nicho...
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia ...very advanced, but may be the future....
The development of relatively well-tolerated and highly active kinase inhibitors...